Medtech Week Recap: UK Department of Health Launches Review of Cosmetic Surgery Products and Procedures
August 20, 2012 – 12:02 amThe UK Department of Health has launched a major review of cosmetic surgery products and procedures. The review is a direct response to concerns raised about the industry following the Pip breast implant controversy, according to the department.Views sought for review of cosmetic procedures (UK Department of Health)
Paul Wilkins, Vice President of Sagentia’s Diagnostics Sector, describes what to take into consideration when developing an IVD device.
Developing Commercially Successful Diagnostic Devices (IVD Technology)
Investing in European medtech companies is becoming increasingly attractive for venture capitalists, a report from fDi Intelligence found.
Europe takes the medtech lead (FASMED)
Harvard University researchers have discovered a new role for the signalling protein VEGF that regulates how bone marrow stem cells turn into bone or fat, a discovery that could lead to new treatments for osteoporosis.
A New View of Osteoporosis (Harvard University)
Editorial: You, Too, Can Drive Healthcare Efficiency (PMPNews)
In this editorial Daphne Allen, Editor of PMPNews, outlines how medical packaging can support efficiency, access and portability.
Tags: cosmetic surgery, Medtech Week Recap, osteoporosis, Pip implant scandal, PVC








